Literature DB >> 22013061

Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.

Jennifer Yinuo Cao1, Sheila Mansouri, Lori Frappier.   

Abstract

Epstein-Barr virus (EBV) infection is causatively associated with a variety of human cancers, including nasopharyngeal carcinoma (NPC). The only viral nuclear protein expressed in NPC is EBNA1, which can alter cellular properties in ways that may promote oncogenesis. Here, we used 2-dimensional difference gel electrophoresis (2-D DiGE) to profile changes in the nuclear proteome that occur after stable expression of EBNA1 in the EBV-negative NPC cell line CNE2. We found that EBNA1 consistently altered the levels of a small percentage of the nuclear proteins. The identification of 19 of these proteins by mass spectrometry revealed that EBNA1 upregulated three proteins affecting metastatic potential (stathmin 1, maspin, and Nm23-H1) and several proteins in the oxidative stress response pathway, including the antioxidants superoxide dismutase 1 (SOD1) and peroxiredoxin 1 (Prx1). Western blot analysis verified that EBNA1 expression upregulated and EBNA1 silencing downregulated these proteins. In addition, transcripts for stathmin 1 were induced by EBNA1, whereas EBNA1 only affected Prx1 and SOD1 at the protein level. Further investigation of the EBNA1 effects on the redox pathway showed that long-term EBNA1 expression in NPC resulted in increased reactive oxygen species (ROS) and increased levels of the NADPH oxidases NOX1 and NOX2, known to generate ROS. In addition, EBNA1 depletion in EBV-positive cells decreased NOX2 and ROS. The results show multiple roles for EBNA1 in the oxidative stress response pathway and suggest mechanisms by which EBNA1 may promote NPC metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013061      PMCID: PMC3255880          DOI: 10.1128/JVI.05648-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.

Authors:  Jie Lu; Masanao Murakami; Subhash C Verma; Qiliang Cai; Sabyasachi Haldar; Rajeev Kaul; Mariusz A Wasik; Jaap Middeldorp; Erle S Robertson
Journal:  Virology       Date:  2010-11-19       Impact factor: 3.616

Review 2.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

3.  EBNA1 regulates cellular gene expression by binding cellular promoters.

Authors:  Allon Canaan; Izhak Haviv; Alexander E Urban; Vincent P Schulz; Steve Hartman; Zhengdong Zhang; Dean Palejev; Albert B Deisseroth; Jill Lacy; Michael Snyder; Mark Gerstein; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma.

Authors:  Takeshi Ogino; Shigetaka Moriai; Yoshiya Ishida; Hideyuki Ishii; Akihiro Katayama; Naoyuki Miyokawa; Yasuaki Harabuchi; Soldano Ferrone
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

5.  Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes.

Authors:  Mahel Zeghouf; Joyce Li; Gareth Butland; Anna Borkowska; Veronica Canadien; Dawn Richards; Bryan Beattie; Andrew Emili; Jack F Greenblatt
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

6.  Proteomic analysis of tobacco mosaic virus-infected tomato (Lycopersicon esculentum M.) fruits and detection of viral coat protein.

Authors:  Juan Casado-Vela; Susana Sellés; Roque Bru Martínez
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

7.  Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes.

Authors:  Ramakrishna Sompallae; Simone Callegari; Siamak Akbari Kamranvar; Maria G Masucci
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

8.  Identification of cellular proteins modified in response to African swine fever virus infection by proteomics.

Authors:  Patricia Alfonso; José Rivera; Bruno Hernáez; Covadonga Alonso; José M Escribano
Journal:  Proteomics       Date:  2004-07       Impact factor: 3.984

9.  Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.

Authors:  Robin Antrobus; Kyle Grant; Bevin Gangadharan; David Chittenden; Roger D Everett; Nicole Zitzmann; Chris Boutell
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

10.  The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs.

Authors:  Michele Trabucchi; Paola Briata; Mariaflor Garcia-Mayoral; Astrid D Haase; Witold Filipowicz; Andres Ramos; Roberto Gherzi; Michael G Rosenfeld
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

View more
  26 in total

1.  Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.

Authors:  Sheila Mansouri; Qun Pan; Benjamin J Blencowe; Julie M Claycomb; Lori Frappier
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

2.  Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.

Authors:  Xuechi Lin; Min Tang; Yongguang Tao; Lili Li; Sufang Liu; Lili Guo; Zijian Li; Xiaoqian Ma; Juan Xu; Ya Cao
Journal:  Cancer Sci       Date:  2012-04-30       Impact factor: 6.716

Review 3.  Oxidative stress in oral diseases.

Authors:  A H Kesarwala; M C Krishna; J B Mitchell
Journal:  Oral Dis       Date:  2015-01-19       Impact factor: 3.511

Review 4.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

Review 5.  Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

Authors:  Deilson Elgui de Oliveira; Bárbara G Müller-Coan; Joseph S Pagano
Journal:  Trends Microbiol       Date:  2016-04-07       Impact factor: 17.079

6.  Reactive oxygen species are induced by Kaposi's sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry.

Authors:  Virginie Bottero; Sayan Chakraborty; Bala Chandran
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

Review 7.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

8.  Identification of cellular proteome using two-dimensional difference gel electrophoresis in ST cells infected with transmissible gastroenteritis coronavirus.

Authors:  Xin Zhang; Hong-Yan Shi; Jian-Fei Chen; Da Shi; Hong-Wu Lang; Zhong-Tian Wang; Li Feng
Journal:  Proteome Sci       Date:  2013-07-16       Impact factor: 2.480

Review 9.  Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival.

Authors:  Lori Frappier
Journal:  Viruses       Date:  2012-09-13       Impact factor: 5.818

Review 10.  Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.

Authors:  Danielle Westhoff Smith; Bill Sugden
Journal:  Viruses       Date:  2013-01-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.